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MitochondriaA metabolic shift from oxidative phosphorylation to glycolysis (i.e. the Warburg effect) occurs in
Alzheimer’s disease accompanied by an increase of both activity and level of HK-I. The ﬁndings
reported here demonstrate that in the early phase of apoptosis VDAC1 activity, but not its protein
level, progressively decreases, in concomitance with the physical interaction of HK-I with VDAC1.
In the late phase of apoptosis, glucose-6-phosphate accumulation in the cell causes the dissociation
of the two proteins, the re-opening of the channel and the recovery of VDAC1 function, resulting in a
reawakening of the mitochondrial function, thus inevitably leading to cell death.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Proper cell activity requires an efﬁcient exchange of molecules
between mitochondria and cytoplasm. Lying in the mitochondrial
outer membrane (MOM), voltage-dependent anion channel (VDAC)
– the most abundant, ancient and highly-conserved protein, previ-
ously considered to be responsible for the almost free permeability
of the MOM [1–4] or a large mesh sieve [5] – unexpectedly soars as
gatekeeper for the entry and exit of mitochondrial metabolites,
thereby controlling cross-talk between mitochondria and the rest
of the cell [3–8]. In higher eukaryotes, three VDAC isoforms –encoded by three separate genes – have been characterized, i.e.
VDAC1, VDAC2 and VDAC3 [9], being VDAC1 the most abundant
in most cells (see [10]). Its location at the boundary between the
mitochondria and the cytosol enables VDAC1 to interact with pro-
teins that mediate and regulate the interrelationship between
mitochondria and other cellular activities. Along with regulating
cellular energy production and metabolism, VDAC1 is also a key
protein in mitochondria-mediated apoptosis, participating in the
release of apoptotic proteins and interacting with antiapoptotic
proteins. Between the mitochondria-interacting proteins which
utilize VDAC1 as anchor point, the one of major interest is hexoki-
nase (HK). Several studies concerning HK claim that, in cells under-
going apoptosis, this enzyme is up-regulated [11], as it happens in
cancer cells which are characterized by a high rate of glycolysis
[12,13] – i.e. the known Warburg effect – and also that the binding
of HK to VDAC1 is somehow involved in the protection against
proapoptotic stimuli [14–18].
Although some evidences supporting the concept that VDAC1
role is cardinal in Alzheimer’s disease (AD) progression exist [19–
23], its precise involvement as a tool to regulate cell bioenergetics
and apoptosis is unknown. Here, we evaluated, in the early as well
in the late phase of apoptosis, the expression level and the activity
of VDAC1 before examining the interaction of VDAC1 with HK-I.
Compelling evidences suggest that glucose-6-phosphate (G6P)
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assuming the attractive role of tip the scales for modulating mito-
chondrial dynamics in AD.
2. Materials and methods
2.1. Cell culture, suspension and homogenate preparation
Primary cultures of cerebellar granule cells (CGCs) were
obtained from dissociated cerebella of 7-day-old Wistar rats, as
in [24]. CGC suspension and homogenate were obtained by (i)
removing the culture medium, (ii) repeatedly washing plated cells
with phosphate-buffered saline (PBS), (iii) scraping cells, (iv) col-
lecting them to have the cell suspension [25] and then (v) breaking
up this last by about 10 strokes with a Dounce homogeniser at
room temperature [see 26,27] to obtain cell homogenate. For pro-
tein content, see [28].
2.2. Induction of apoptosis and assessment of neuronal viability
Apoptosis was induced at 6–7 days in vitro, as reported in [29].
Apoptotic and control cells are referred to as S-K5 and S-K25 cells,
respectively. Viable CGCs were quantiﬁed as in [30].
2.3. Mitochondrial function measurements
Oxygen consumption was measured by means of a Gilson 5/6
oxygraph using a Clark electrode, as in [27]. ANT-1 and VDAC1
activities were estimated by following the exchange ADP/ATP
across mitochondrial membranes measured as in [27], in the
absence or in the presence of either atractyloside (ATR) or 4,40-diis-
othiocyanostilbene-2,20-disulfonic acid (DIDS), i.e. cell permeable
blockers of ANT and VDAC1 [31–33], respectively. The rationale
for this approach is described in the Results section. Cytochrome
oxidase activity was assayed essentially as in [34,35].
2.4. Lipid peroxidation
Lipid peroxidation was detected by using the sensitive tech-
nique of cis-parinaric acid (PnAc) ﬂuorescence loss, as in [35].
2.5. HK assays
The activity of HK was assayed spectrophotometrically at
340 nm under Vmax conditions, as in [11].
2.6. Determination of G6P in cells incubated with glucose
Glucose (GLU), at concentrations and for times reported in the
legend, was incubated with plated cells. When the incubation time
was terminated, removal of the glucose-containing medium, dou-
ble washing of the cell layer and replacement with fresh medium
were made. Immediately after, apoptosis was induced (see above).
G6P was assayed, essentially as in [36], in cell homogenate either
before apoptosis induction, i.e. time = 0, or after the apoptosis
induction time, i.e. 3 h. Our care has been ensuring that the accu-
mulation of G6P in cell does not substantially change, i.e. G6P level
does not undergo an obvious metabolism-dependent decline, dur-
ing the time of apoptosis induction. The use of inhibitor/s of
G6PDH was avoided to prevent uncontrollable side effects and so
operate under conditions closest to those physiological.
2.7. Western blot analysis
Cell lysis and Western blot analysis were performed mainly as
in [37]. Brieﬂy, equal amounts of protein were subjected toSDS–PAGE on 11% Tricine–SDS–polyacrylamide gels [38], blotted
onto PVDF membranes and then probed with polyclonal anti-HK-
I (AB3543, Millipore, Temecula, CA, USA) and monoclonal anti-b-
actin antibodies (A4700, Sigma Chemical Co., St. Louis, MO, USA).
HRP-conjugated secondary antibodies were used for detection fol-
lowed by enhanced chemiluminescence development.
2.8. Co-immunoprecipitation
Cells were lysed in 1 % Triton X-100, 150 mM NaCl, 20 mM Tris-
HCl, 1 mM EGTA, 1 mM EDTA, 1 mM DTT pH 7.2, for 10 min at 4 C
in the presence of protease and phosphatase inhibitor cocktails.
Lysates were then centrifuged at 4 C for 10 min at 960g. The pro-
tein extracts (500 lg) were immunoprecipitated by Protein A/G
PLUS-Agarose according to the manufacturer’s instructions using
7 lg of polyclonal anti-HK-I antibody. After overnight incubation
at 4 C, the immunocomplexes were eluted with Laemmli buffer
2 and were next analyzed by immunoblotting with the
monoclonal anti-VDAC1 antibody (MABN504, Millipore, Temecula,
CA, USA).
3. Results and discussion
3.1. VDAC1 activity and protein level in cells undergoing apoptosis
VDAC1 translocates a variety of metabolites, including ATP and
ADP, across the mitochondrial outer membrane. In order to esti-
mate its activity, an experimental strategy allowed us to follow
the ADP/ATP exchange measuring VDAC1 and ANT-1 activities in
the same experiment. To start with, the measurement of ADP/
ATP exchange was carried out in homogenates from S-K25 cells
in the absence or presence of compounds designed to block VDAC1,
i.e. DIDS (20 lM), or ANT-1, i.e. ATR (2 lM). In a typical experiment,
cell homogenate was treated with AP5A (10 lM) to inhibit adenyl-
ate kinase [for Ref. see 21], thus preventing mitochondrial ATP syn-
thesis in a manner not dependent on oxidative phosphorylation,
and then incubated in the presence of an ATP detecting system
(see Ref. [27] for methodological details). The ATP concentration
in the extramitochondrial phase of the homogenates was negligi-
ble as shown by the fact that no increase in the absorbance mea-
sured at 340 nm was found in the presence of glucose,
hexokinase, glucose-6-phosphate dehydrogenase and NADP+. As a
result of ADP addition (0.04 mM), an increase in the NADPH
absorbance was observed, indicating the appearance of ATP in
the extramitochondrial phase. The rate of NADPH formation was
approximately 10 nmol NADP+ reduced/min mg cell protein
(Fig. 1Aa), in good agreement with values obtained by Atlante
et al. [26]. NADPH formation derives from (i) ADP uptake into
mitochondria in exchange for endogenous ATP, (ii) ATP synthesis
from imported ADP via ATP synthase and (iii) efﬂux of the newly
synthesized ATP from the mitochondria in exchange for further
ADP. A decrease of NADPH formation (Fig. 1Ab-c) was recorded
in the presence of DIDS or ATR (3.2 and 5.5 natoms/min mg pro-
tein, respectively), showing that (i) the exchange of ADPext with
ATPint exclusively occurs through the outer and inner mitochon-
drial membranes, respectively; (ii) both the membranes are intact
and (iii) the exchange is mediated by protein/s.
Applying the control strength criterion and using DIDS at differ-
ent concentrations (Fig. 1B), we observed that the rate of absor-
bance increase, i.e. ADP/ATP exchange, in the absence of inhibitor
was lower than the value corresponding to the straight line that
intercepts the Y-axis at zero inhibitor concentration – obtained
by interpolating the experimental points of absorbance increase
rate in the presence of DIDS – thus showing that (i) the inhibited
step of measured processes, i.e. the ADP/ATP exchange across
MOM via VDAC1, is not the limiting step and (ii) the reciprocal
Fig. 1. VDAC1 activity and protein level in cells undergoing apoptosis. (A) Appearance of ATP due to addition of ADP (0.04 mM) to CGC homogenate (0.1 mg protein) from S-
K25 cells was monitored, either in the absence (a) or in the presence of 20 lM DIDS (b) and 2 lM ATR (c), added to cell homogenate 1 min before ADP addition, by using an
ATP detecting system consisting of glucose (2.5 mM), HK (0.5 e.u.), G6PDH (0.5 e.u.) and NADP+ (0.2 mM) in the presence of P1,P5-di(adenosine-50)penta-phosphate (AP5A), a
speciﬁc inhibitor of ADK. The rate of NADP+ reduction in the extramitochondrial phase was followed as the absorbance increase at 334 nm, measured as the tangent to the
initial part of the progress curve and expressed as nmoles NADP+ reduced per min per mg cell protein. (B) Appearance of ATP due to addition of ADP (0.04 mM) to CGC
homogenate (0.1 mg protein) from S-K25 cells was monitored, as in A, either in the absence (s) or in the presence of DIDS (N) and ATR (d) at the indicated concentrations.
Reported values are the mean of three independent neuronal preparations (with comparable results), each one in triplicate, with the standard deviation. (C) The values of
VDAC1 activity, calculated at different times after apoptosis induction and expressed as % of control, are reported (for details see Section 3). (D) VDAC1 protein expression.
Cell lysates from either control (S-K25) or apoptotic CGCs (S-K5), at 3 and 8 h, were analyzed by Western blotting analysis with anti-VDAC1 antibody, as described in Section
2. Antibodies against b-actin were used to normalize the protein amount loaded onto the gel.
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ited process, i.e. VDAC1 activity. This was true also for all the con-
sidered times of apoptosis (not shown).
In contrast, the intercept of the Y-axis in the case of the ADP/
ATP exchange, inhibited by ATR, coincides with the rate value in
the absence of inhibitor, according to [27].
Then, to determine the activities of VDAC1 in S-K5 cells at differ-
ent times after low potassium-apoptosis induction, the reciprocals
of the intercept to the Y-axis were analyzed, essentially as reported
in [39,11], and showed a decrease in activity which starts as soon as
10 min after apoptosis induction (Fig. 1C). The maximum enzyme
activity decrease in S-K5 cell homogenate (about 40%) was mea-
sured 3 h after potassium shift, time at which VDAC1 activity
undergoes a sharp reversal trend, with progressive increase up to8 h, when it returns to values similar to control. Worthy of note is
the fact that here, for the ﬁrst time, the activity of VDAC1 has been
measured in conditions close to the physiological ones. In fact, as
for any membrane protein responsible for exchange of solutes
across a membrane, the functional properties of VDAC have always
been examined in reconstituted systems with artiﬁcially prepared
phospholipid bilayers [see 40]. As expected [27], a progressive
decrease of activity of ANT-1 in cell undergoing apoptosis was
observed (not shown). Importantly, variations in VDAC1 activity
take place in cell undergoing apoptosis (at 3 and 8 h after K+-shift)
regardless of the relative abundance of the protein, as checked by
Western blotting analysis on whole-cell extracts (Fig. 1D), proving
thus that its regulation under our in vitro conditions was not
attributable to differences in intracellular expression levels but
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mortem brain of AD patients, VDAC1 and/or VDAC2 levels are sig-
niﬁcantly reduced or elevated in different brain regions [19], as well
VDAC1 is overexpressed in the hippocampus from amyloidogenic
AD transgenic mice models [21].
3.2. VDAC1 interacts with HK-I. Effect of DIDS
We have recently demonstrated that, in the early phase of
apoptosis, glucose metabolism is enhanced with up-regulation of
key proteins which internalize and metabolize glucose, such as
HK-I, while a parallel decrease in oxygen consumption by mito-
chondria occurs [11].
In order to investigate whether in our cell model of apoptosis
HK-I interacts with VDAC1 at the MOM – as it occurs in cancer cells
[see 9] – coimmunoprecipitation experiments on whole cell
extracts were performed from apoptotic samples at 3 and 8 h after
K+-shift – and relative controls – using polyclonal anti-HK-I anti-
body as bait-antibody, followed by immunoblotting with a
monoclonal antibody which speciﬁcally interacts with VDAC1. AsFig. 2. VDAC1 interacts with HK-I. Effect of DIDS. (A) Lysates of either control (S-K25) or
HK-I antibody and immunoprecipitated samples were probed for VDAC1. (B) The activi
expressed as % of control (for details see Section 3). All assays, performed at least in d
survival to DIDS in cells undergoing apoptosis. Rat CGCs (2  106/well) at 7 DIV were i
culture medium. Where indicated DIDS, at different concentrations, was added to cultur
compound-containing medium, (ii) twice washing of cell layers and (iii) S-K25- or S-K5-
intact nuclei, is expressed as the percentage of the S-K25 cells to which a value of 100% ha
of six different experiments carried out with different cell preparations from different g
when compared the sample with S-K5 cell. The lack of asterisk indicates no statistically s
at 3 and 8 h, treated or not with 250 lM DIDS for 120 min as described above, were subj
probed for VDAC1.shown in Fig. 2A, VDAC1 coimmunoprecipitated with HK-I sug-
gesting that the VDAC1/HK-I complex was present in SK5 cells at
3 h after apoptosis induction. Surprisingly, in 8 h-S-K5 cells the
VDCA1 signal dramatically decreased and became roughly similar
to the faint signal detected in control cells, at both 3 and 8 h, thus
suggesting that the stability of VDAC1/HK-I complex was inversely
associated with apoptosis progression. In this regard, Azoulay-
Zohar et al. [41] showed that HK-I directly interacts with bilayer-
reconstituted VDAC to induce closure of the VDAC channel in a
manner that is reversed by G6P. In addition, HK-I and VDAC have
been co-immunoprecipitated [42]. Moreover, mutagenesis studies
revealed that a single mutation in VDAC1 prevented HK-I-medi-
ated protection against apoptosis and channel closure [43], while
N-terminally truncated VDAC1 lost its HK-I binding capacity [44].
In the experiments reported in Fig. 2B, both VDAC1 (N) and HK-I
(d) activities, measured as in Fig. 1 and in [11] respectively, were
reported as a function of time (0–8 h) of apoptosis. As shown, the
rate of ADP/ATP exchange, via VDAC1, at 0.04 mM ADP, decreased
up to 3 h; in the same time range, HK-I increased. After 3 h a
reverse trend of the activities occurred: the activity of VDAC1apoptotic CGCs (S-K5), at 3 and 8 h, were subjected to immunoprecipitation by anti-
ties of VDAC1 and HK-I, calculated at different times after apoptosis induction, are
uplicate, were at 25 C and pH 7.2 to mimic intracellular pH. (C) Sensitivity of cell
ncubated either in high potassium (S-K25) or in low potassium (S-K5) serum-free
ed S-K25 or S-K5 CGCs for 120 min, with exposure terminated by (i) removal of the
medium replacement. Cell survival, measured after 24 h by counting the number of
s been given. Results are means ± S.D. of triplicate measurements and representative
roups of animals. Statistical analysis was by ANOVA and Bonferroni test: ⁄p < 0.001
igniﬁcant differences. (D) Lysates of either control (S-K25) or apoptotic CGCs (S-K5),
ected to immunoprecipitation by anti-HK-I antibody and immunoprecipitated were
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which VDAC1/HK-I complex was destroyed (Fig. 2A), the activities
of both enzymes tended to the control values. Then all the results
suggest that the activity of VDAC1 strictly depends on physical
interaction with HK-I. It is low when HK-I, bound to the cytosolic
face of VDAC1, acts as a gate, affecting mitochondrial and overall
cellular bioenergetics, while it tends to rise when the binding is
destroyed. Since this disruption favors a VDAC1 conformational
state more prone to the release of proapoptotic factors [see 9], reg-
ulation of the function of this channel may be a promising thera-
peutic approach to combat AD. Consistently, some reports have
shown that in tumors the HK–VDAC1 interaction prevents apopto-
sis [17,41,43,45], while disruption of HK–VDAC1 binding via muta-
genesis of key amino acids on VDAC, signiﬁcantly enhances
induction of apoptosis [46].
Before investigating the role of G6P – whose level increases in
cell undergoing apoptosis [11] – which, as known, acts as allosteric
inhibitor of HK, we have examined the effect of DIDS on both cell
viability and VDAC1–HK-I binding (Fig. 2C and D). When the
responsiveness of S-K5 cells to increasing DIDS concentrations
was checked at 24 h, a strong prevention of death was observed
in the presence of 250 lM DIDS (Fig. 2C), which was without effect
on the survival of S-K25 control cells, consistently with [31]. On the
other hand, the same DIDS concentration (250 lM) had no effect
on the VDAC1–HK-I binding since it did not attenuate the band
intensity at 3 h which was comparable to that obtained in the
absence of the VDAC blocker (Fig. 2D). These results are notewor-
thy and conﬁrm the above Fig. 2A and B: knock out the VDAC1,
either by the interaction with HK-I or with the channel blocker,
is an advantage for the cell, which attempts to oppose the impend-
ing catastrophe, and confers an anti-apoptotic role to HK-I when
bound to VDAC1. Consistently, disruption of HK binding to VDAC1
by mutation in VDAC1 or by addition of VDAC1-based peptides
decreased the survival of cells [47], data supported by the ﬁnding
that cisplatin-induced apoptosis is inhibited in cells silenced for
VDAC1 expression [23,48,49], in which, for more, the mitochon-
drial maintenance and function is improved and may protect
against toxicities of AD-related genes.
3.3. G6P accumulation detaches HK-I from VDAC1 and restores
mitochondrial function
In a recent paper [11], we show that CGCs upregulate Warburg
effect-enzymes in a manner reminiscent of cancer cells, in the early
phase of apoptosis, thus mimicking the apoptotic resistance mech-
anism of surviving neurons in the AD brain. This situation is char-
acterized by (i) high aerobic glycolysis and suppression of
mitochondrial respiration, (ii) high expression of HK-I which binds
to the MOM via a speciﬁc association with VDAC1 [see 50 and
results of Fig. 2] and (iii) G6P accumulation, whose level gradually
rises in S-K5 cells. In this context, G6P, the product of HK reaction,
antagonizes binding to VDAC1 and leads to release of HK-I from
mitochondria [see 50], then opening VDAC1 and allowing mito-
chondria to resume their normal aerobic metabolism, including
uptake of ADP, Pi and respiratory substrates, oxidative phosphory-
lation, and release of ATP into the cytosol.
We have collected several and compelling evidences proving
that HK-I, clinging to VDAC1, inhibits the channel in cells simulat-
ing an AD-like situation. In order to investigate the action of G6P in
neurons undergoing apoptosis, we incubated plated cells with GLU
with the aim of researching the experimental condition that
ensures (i) an accumulation of G6P into cell and that (ii) G6P high
levels remain as such in the time range required to perform the
measurements. Fig. 3A0 and A00 reports G6P assay in cells added
with (i) GLU at different concentrations for 30 min (A0) and (ii)
GLU (25 mM) for different incubation times (A00). As a control,phloretin (PHLO, 50 lM), a speciﬁc inhibitor of glucose transport
[51], prevents G6P accumulation (Fig. 3A0). In Fig. 3A000, cytosolic
G6P level has been monitored in the times following the incuba-
tion period with 25 mM GLU: G6P remained roughly high up to
3 h (about 80–85% with respect to time = 0, i.e. immediately after
the 30 min incubation of cells with GLU), thus conﬁrming that
G6P accumulation lasts for all the time required by the experimen-
tal conditions.
To determine whether mitochondrial function is affected in
G6P-loaded-S-K5 cells, we measured VDAC1 activity, oxygen con-
sumption, lipid peroxidation and cytochrome oxidase activity in
cells at 3 h after K+-shift, time at which (i) the maximum decrease
of VDAC1 activity and (ii) the change of trend of the VDAC1 activity
occurs, as compared to unloaded S-K5 cells. VDAC1 activity
increases (27%) with respect to the control (Fig. 3B), suggesting
that G6P reverses blockade of VDAC1 conductance. Control was
made that G6P was without effect when added to the cuvette in
which VDAC1 activity was assayed (not shown). This result simply
allows mitochondria to resume operation: oxygen consumption by
glucose increases (30%) (Fig. 3C), due to the mitochondrial respira-
tory chain (mRC) that resumes to work at a high rate. As expected,
a greater loss of ﬂuorescence of cis-Parinaric acid (PnAc), i.e. a
higher membrane lipid peroxidation, is observed (20%) in G6P-
loaded-S-K5 cells, indicating that the G6P-dependent resumption
of VDAC1 may enhance the lipid peroxidation (Fig. 3D), likely
due to increased production of mitochondrial superoxide anions
at the mRC level. To conﬁrm this hypothesis, about 25% G6P-
induced COX inhibition was observed, almost completely pre-
vented by either 5 U/ml SOD or 250 lM DIDS (Fig. 3E), thus allow-
ing to propose that the effect of G6P on COX activity – which, as
known is cardiolipin-dependent [35] – is ROS-mediated. As
expected, a HK-I activity decrease (35%) was found under these
experimental conditions, i.e. in G6P-loaded cells (Fig. 3F). All these
data strongly suggest that G6P, accumulated into cells before apop-
tosis starts, partially prevents the HK-dependent closure of VDAC1,
and that the HK anchorage at VDAC1 is a reversible process in cell
acting not only as the ‘‘guardian of mitochondria’’ but, more inter-
estingly, as a promising target for developing novel therapeutic
approaches against neurodegeneration.4. Conclusions
Our results suggest that HK-I regulates apoptotic cell death via
interaction with and closure of VDAC1 in a fruitless attempt to
promote cell survival. Therefore, as a result, VDAC1 stands acting
as a ‘governator’ of mitochondrial function, establishing set points
for global mitochondrial activity that change in response to cellu-
lar needs and metabolic stresses. Within this scenario, a leading
ﬁgure is that of G6P, whose level, along with L-lactate and
NADH/NAD+ ratio (see [11]), raises in cells which – when sub-
jected to an apoptotic stimulus – activate a Warburg effect-like
mechanism [11]. The overall process occurring in the course of
CGC apoptosis, is the sum of the consequent steps illustrated in
Scheme 1:
(i) high level of HK-I [11] causes its physical anchorage to
VDAC1 (Fig. 2A), whose activity, but not the protein level,
decreases in the early phase of apoptosis (Fig. 1A and B);
(ii) mitochondrial function is then impaired, while glycolysis
speeds up [11];
(iii) no Mitochondrial respiration, no ROS production, no ROS
leakage: the HK-I–VDAC1 binding keeps low the oxidative
stress in cell;
(iv) inhibition or down-regulation of a metabolic glycolysis step
[see 11] causes higher level of G6P;
Fig. 3. Cell G6P accumulation restores mitochondrial function. (A)G6P accumulation inside the cells. In A0-A00 , glucose (GLU) was added to plated cells at different
concentrations (A0), either in the absence (d) or in the presence of phloretin (N, 50 lM) for 30 min or at 25 mM for different times (A00). At the indicated time, cells were lysed
and G6P was assayed (see Section 2). In A000 , after the 30 min incubation period with GLU, G6P level was assayed at different times up to 3 h, time of apoptosis. (B) VDAC1
activity was assayed, as reported in Fig. 1, both in unloaded (control) and in G6P-loaded S-K5 cells, and expressed as % of control. (C) Oxygen consumption. Externally added
glucose (5 mM) to the cell suspension causes oxygen consumption (v = 25 natom O/min mg cell protein) as a result of a multistep process consisting of glucose transport
across the cell membrane, entry into the glycolytic pathway, pyruvate uptake by mitochondria where oxidative decarboxylation via the PDC occurs, citric cycle and oxidative
phosphorylation. The rate of oxygen consumption was expressed as % of control. (D) Lipid peroxidation. Unloaded- or G6P-loaded S-K5 cell homogenate (0.25 mg/ml),
containing mitochondria, were preincubated with 5 lM cis-Parinaric acid for 15 min in the dark with stirring at 25 C. Then the suspensions were centrifuged and the pellets
were resuspended in 2.0 ml of PBS (see Section 2). The ﬂuorescence (318 nm excitation and 410 nm emission) in arbitrary units was recorded for 30 min. Fluorescence values
at the beginning of the reaction (t0) minus the value measured after 30 min (t30) are reported as an index of lipid peroxidation (a.u.). (E) COX activity was determined by
measuring O2 consumption polarographically in the oxygen electrode chamber where cell homogenate was incubated at 25 C in 2.0 ml respiration medium (210 mM
mannitol, 70 mM sucrose, 20 mM Tris/HCl, 5 mM KH2PO4/K2HPO4, pH 7.4, 3 mM MgCl2). The activity reaction was initiated by adding 5 mM ascorbate plus 0.2 mM
tetramethyl p-phenylenediamine to the cell CGC homogenate (0.1 mg protein) of unloaded- or G6P-loaded S-K5, subjected to three freeze–thaw cycles to disrupt membranes
and expose enzymes, and expressed as % of control. SOD (5 U/ml)or DIDS (250 lM) were present where indicated. (F) HK-I activity was assayed, as reported in Section 2, both
in unloaded- and in G6P-loaded S-K5 cells, and expressed as % of control. Statistical analysis was by ANOVA and Bonferroni test: ⁄p < 0.05, ⁄⁄p < 0.01 when compared G6P-
loaded with unloaded cells. The lack of asterisk indicates no statistically signiﬁcant differences.
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Scheme 1. Time course of apoptosis: the protective effect of HK-I binding to VDAC1 is lost in time with apoptosis progression. (A) In the early phase of apoptosis, glycolysis
speeds up, VDAC1 activity decreases due to HK-I binding, mitochondria operate at low capacity and oxidative stress is hold back. (B) In the late phase of apoptosis, G6P level
increases and detaches HK-I from VDAC1 which restores its full activity. Mitochondria work at full capacity, oxidative stress grows up and cell irreversibly proceed to death.
For details see text.
A. Bobba et al. / FEBS Letters 589 (2015) 651–658 657(v) G6P accumulation (Fig. 3A0–A000) (i) ‘‘causes’’ detachment of
HK-I from VDAC1, which then recovers its function, and
(ii) functions as an alarm clock for mitochondrial function
(Fig. 3B–F), which, as reported in [11], was apparently
numb;
(vi) then, in the late phase of apoptosis, a functional VDAC1 is
required for the progression of apoptosis, both of them
blocked by DIDS (Table to Figs. 1A and 2D).
In conclusion, these results suggest that both glucose phosphor-
ylation and mitochondrial binding to VDAC1 contribute to the pro-
tective effects of HK-I, consistently with [41–47,52 and refs
therein], showing that HK-I binding to the mitochondria inhibits
apoptosis.
Future research will be needed to determine the merits of this
hypothesis and investigate on the molecular mechanism by which
VDAC1 channelling may be also modulated by AD proteins, such as
tau fragment and Ab. In this regard, recent research revealed that
VDAC1 interacts with phosphorylated tau and Ab and that these
interactions progressively increased with disease progression [53].
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